Written by Klarity Editorial Team
Published: Dec 26, 2025

For millions of Americans living with ADHD, medications like Vyvanse (lisdexamfetamine) can be life-changing. However, accessing these Schedule II controlled medications through telehealth has become increasingly complex due to evolving federal regulations and state-specific requirements. With the DEA’s pandemic flexibilities set to expire on December 31, 2025, patients and providers are navigating a shifting landscape of rules that vary dramatically based on location, provider type, and specific medication.
This comprehensive guide clarifies the legal pathways to obtaining Vyvanse and other Schedule II stimulants through telehealth, helping you understand what’s possible, what’s prohibited, and how to ensure you’re receiving care through legitimate, compliant channels.
The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 generally requires an in-person examination before prescribing controlled substances. However, during the COVID-19 public health emergency, the DEA implemented temporary exceptions allowing for the remote prescribing of controlled substances, including Schedule II medications like Vyvanse.
These flexibilities have been extended multiple times and are currently set to expire on December 31, 2025. Under these temporary rules, qualified practitioners can prescribe Schedule II controlled medications like Vyvanse via telehealth under the following conditions:
After the current flexibilities expire, the DEA is expected to implement a special registration system for telemedicine prescribing of controlled substances. This system, mandated by the SUPPORT Act of 2018 but not yet implemented, would create a formal pathway for qualified providers to legally prescribe controlled substances via telehealth.
Until this special registration process is finalized, patients established during the COVID-19 flexibility period may be required to attend an in-person examination to continue their medication, though the specific requirements remain uncertain.
Federal regulations establish minimum requirements, but states can implement additional restrictions. This creates a patchwork of rules that significantly impacts telehealth prescribing:
Most states mandate prescriber consultation with the state’s Prescription Monitoring Program before prescribing Schedule II medications:
The authority to prescribe Schedule II medications varies dramatically by provider type and state:
| State | MD/DO Authority | Nurse Practitioner Authority |
|---|---|---|
| Texas | Full prescribing authority | Restricted to hospital/hospice settings for Schedule II |
| Florida | Full prescribing authority | PMHNPs can prescribe with physician supervision |
| New York | Full prescribing authority | Independent prescribing with 3,600 hours experience |
| Illinois | Full prescribing authority | Full independent prescribing after transition period |
| California | Full prescribing authority | Schedule II prescribing requires physician supervision |
This table explains why you might hear conflicting information about whether nurse practitioners can prescribe Vyvanse via telehealth—it depends entirely on your state’s regulations.
Some telehealth providers may prefer prescribing Vyvanse over immediate-release stimulants like Adderall for several reasons:
Prodrug Mechanism: Vyvanse is a prodrug that requires enzymatic conversion in the body to become active, which may reduce abuse potential compared to immediate-release stimulants.
Once-Daily Dosing: Vyvanse’s extended-release formulation allows for once-daily dosing, improving adherence and reducing concerns about multiple daily doses.
Smoother Pharmacokinetic Profile: The gradual release mechanism creates fewer peaks and troughs in medication levels, potentially reducing side effects.
However, these clinical advantages must be weighed against practical considerations:
At Klarity Health, our providers understand these complex regulations and guide patients through the proper assessment process while maintaining full compliance with state and federal requirements. We work with both insurance and self-pay patients to make the process as smooth as possible while ensuring all legal requirements are met.
Be wary of telehealth services that:
Vyvanse’s cost can be a significant barrier, with retail prices often exceeding $400 for a month’s supply. Consider these approaches:
Insurance Coverage: Work with providers who accept insurance and can complete prior authorization requirements
Patient Assistance Programs: Takeda Pharmaceuticals offers help for qualified patients through their patient assistance program
Generic Alternatives: Generic lisdexamfetamine has recently entered the market, potentially offering cost savings
Alternative Medications: Discuss with your provider whether other stimulant or non-stimulant options might be appropriate and more affordable
Obtaining Schedule II medications like Vyvanse through telehealth requires navigating complex federal and state regulations, but legitimate pathways do exist. Understanding your state’s specific requirements and working with compliant providers ensures you receive proper care while avoiding legal complications.
As we approach the December 31, 2025 deadline for current flexibilities, staying informed about regulatory changes will be crucial for maintaining continuity of care. Consider establishing care with a telehealth provider like Klarity Health that emphasizes compliance, transparent pricing, and access to qualified providers who understand both the clinical and regulatory aspects of ADHD treatment.
Can I legally get Vyvanse prescribed through telehealth?Yes, under current DEA flexibilities (until December 31, 2025), Vyvanse can be prescribed via telehealth if the encounter includes audio-visual technology and complies with state-specific regulations.
Can nurse practitioners prescribe Vyvanse via telehealth?It depends on your state. Some states allow NPs full prescribing authority for Schedule II medications, while others restrict or prohibit NP prescribing of stimulants.
Will I need an in-person visit after December 31, 2025?Unless the DEA implements its special registration system before then, patients may need an in-person evaluation to continue receiving Schedule II medications after current flexibilities expire.
How often do I need new prescriptions for Vyvanse?Schedule II prescriptions cannot include refills,
Find the right provider for your needs — select your state to find expert care near you.